ReviewThe American journal of psychiatry2026
The Evolving ADHD Phenotype in the Externalizing Context.
Review in The American journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cognitive Disengagement Syndrome Symptoms and ADHD Dimensions in Relation To Children's Daily Life Executive Functioning Deficits.Research on child and adolescent psychopathology · 2026Article
- Cognitive and emotional profiles in children with ASD, ADHD, and comorbid presentations: evidence for a distinct clinical phenotype.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Attention deficit hyperactivity disorder (ADHD) is a developmental precursor for future conduct and other externalizing problems. Despite its familiarity, research in the past decade suggests that refining the ADHD phenotype will yield dividends for clinical prediction and treatment specification as well as mechanistic discovery and theory. ADHD is a useful category, yet it comprises multiple constitutive traits requiring further specification. The field is now poised to shift to a useful integration of novel dimensional traits into a refined ADHD phenotype. This shift will need to recognize the importance of both the established ADHD symptom dimensions and other trait dimensions to create new presentations, types, or specifiers in the nosology. Clinical issues include the role of sluggish, disengaged cognitive style of inattention with hypoactivity. Dispositional traits related to emotional dysregulation will be key as well; these include negative affect and irritability (anger dysregulation). In the cognitive sphere, along with ongoing work on executive functions and reward discounting, new insights related to cognitive information gain or neural gain (a mechanism by which relevant neural connections strengthen during rapid information uptake and decision making) may explain other cognitive findings and relate to dispositional traits and clinical features. Due to its early gateway role, clinical prediction algorithms to evaluate course of ADHD and advisability of intervention will be valuable. A neurodevelopmental, early origins perspective, including early developmental programming in the prenatal period, is increasingly informing etiological understanding of ADHD. Nonclinical trait measures are seen as early precursors of ADHD, and ADHD is then a precursor of more serious externalizing and other complications later. This view opens new opportunities for risk detection and prevention. Clinical prediction algorithms should benefit from inclusion of low-cost, readily deployable trait measures discussed here, including selected temperament and cognition measures, which appear to enhance predictive power.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.